Rapamycin inhibited the translation of cell cycle and cancer growth-promoting genes such as p70-S6K, explaining the anti-proliferative effect of rapamycin on pancreatic cancer cells. This evidence concerns the gene RPS6KB1 and familial pancreatic carcinoma.